WOBURN, Mass., Feb. 23, 2017 /Weed Wire/ — Courtagen Life Sciences, Inc., an innovative endocannabinoid platform and molecular information company, announced today that the company has received a Notice of Allowance from the United States Patent and Trademark Office for its patent application no. 14/895,557, titled “Methods and Kits for Treating and Classifying Individuals at Risk of or Suffering from TRAP1 Change-of-Function.”
Tag Archives: Mike Catalano
CannMed 2017 Conference Announces Expanded Speaker List for Medical Cannabis Health and Research Conference to be Held in Boston in April
WOBURN, Mass., Feb. 10, 2017 /Weed Wire/ — Medicinal Genomics and Courtagen Life Sciences, today announced an increasingly influential speaker lineup for CannMed 2017.
Medicinal Genomics Receives NIDA Grant to Develop Novel Toxin Detection Test for Medical Cannabis
WOBURN, Mass., Jan. 25, 2017 /Weed Wire/ — Medicinal Genomics (MGC) and Courtagen Life Sciences today announced that the National Institute on Drug Abuse (NIDA) has awarded the company an SBIR Phase I grant to develop a novel test to detect toxins resulting from microbiological contamination of medical cannabis.
CannMed 2017 Conference to Offer Doctors an Opportunity to Earn CME Credits to Learn about Cannabis Medicine
WOBURN, Mass., Jan. 12, 2017 /Weed Wire/ — Courtagen Life Sciences and Medicinal Genomics today announced a partnership with TheAnswerPage.com to provide continuing medical education (CME) credits to physicians and other healthcare professionals for the upcoming CannMed 2017 Personalized Cannabinoid Medicine Conference